About Avisi
Our Story
Avisi Technologies was founded in 2017 through the University of Pennsylvania Y-Prize program. At the time, Avisi’s founders dreamed of applying novel nanotechnologies to combat vision loss and prevent blindness. Through interdisciplinary efforts across materials science engineering and ophthalmology, the VisiPlate technology was born. With initial support from the President’s Innovation Prize, National Science Foundation SBIR grants, MedTech Innovator, and more, Avisi accelerated its growth significantly.
Today, Avisi’s diverse and expert team remains committed to our mission to restore health and promote vitality. Together we’ll create a world with accessible, cutting-edge healthcare solutions for all.
Leadership
Rui Jing Jiang
Founder, CEO, and Director
Jeff Emery, PhD
Senior VP of R&D and Operations
Georgia Griggs, MSE
Principal Engineer, Site Head
Kim Du, CCRP
Senior Director of Clinical Operations
Catherine Mohr, MD, MSME
Director of the Board
Gary Pruden
Director of the Board
Paul Norris, JD
Director of the Board
Brandon Kao
Founder and Director
Scientific Advisory Board
Eydie Miller-Ellis, MD
Director of the Glaucoma Fellowship Program at Scheie Eye Institute and Professor of Clinical Ophthalmology at University of Pennsylvania
Website
Richard A. Lewis, MD
Former Director of Glaucoma at the University of California, Davis, past President of ASCRS, past President of American Glaucoma Society, and Co- Founder, Sacramento Eye Consultants
Website
Iqbal (Ike) K. Ahmed, MD, FRCSC
Head of Ophthalmology at Trillium Health Partners, Chief Innovation Officer at Prism Eye Institute, Professor of Ophthalmology at University of Utah and John Moran Eye Center
Website
Ehsan Sadri, MD, FACS, FAAO
Founder and CEO of Visionary Eye Institute, Founding Board Member of Visionary Ventures Fund.
Website
Vance Thompson, MD
President of ASCRS, Director of Refractive Surgery at Vance Thompson Vision, Professor of Ophthalmology at Sanford USD School of Medicine
Website
Jonathan S. Myers, MD
Director of Wills Eye Hospital Glaucoma Service and Professor, Sidney Kimmel Medical College at Thomas Jefferson University
Website
Vivian Lee, MD
Co-director of the William C. Frayer Ophthalmic Pathology Laboratory and Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania
Website
Georges Durr, MD, FRCSC
Surgeon at CHUM, Associate Clinical Professor at the University of Montreal
Website
Joseph F. Panarelli, MD
Director of Glaucoma Services and Professor of Ophthalmology at New York University School of Medicine
Website
Join Our Team: Shape the Future of Healthcare
Avisi’s mission is to restore health and promote vitality. We envision creating a world with accessible, cutting-edge healthcare solutions for everyone.
As part of our team, you will be at the forefront of developing the next-generation treatment for glaucoma, the world’s leading cause of irreversible blindness.
- For information on full-time position openings, you can follow our LinkedIn where we post openings.
- Interns at Avisi have the opportunity to work on 1-2 projects over an 8-10 week period.
- We are always happy to meet students who have an interest in MedTech innovation. Interns gain the most when they have already completed at least 2 years of undergraduate coursework and research.
For full-time employment and internship opportunities feel free to reach out to info@avisitech.com.
Supporting Our Vision: Partners in Progress
Avisi is supported by a network of venture investors, esteemed universities, the National Science Foundation (NSF), and industry groups like AdvaMed Accel. Our journey is further highlighted by our membership in Johnson & Johnson’s JLABS incubator and our alumni status with the MedTech Innovator Accelerator and UCSF Rosenman Innovator programs.
If you’re interested in investment opportunities please contact info@avisitech.com.
Supported by
